Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susanne Hille

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
Cells|February 11, 2023
C1q and Tumor Necrosis Factor Related Protein 9 Protects from Diabetic Cardiomyopathy by Alleviating Cardiac Insulin Resistance and InflammationRicarda Haustein, Felix A Trogisch, Merve Keles, et al.
JACC. Basic to Translational Science|May 17, 2021
FYCO1 Regulates Cardiomyocyte Autophagy and Prevents Heart Failure Due to Pressure Overload In VivoChristian Kuhn, Maja Menke, Frauke Senger, et al.
Nature Cardiovascular Research|June 16, 2026
Selective titin cleavage disrupts cardiac mechanical homeostasis to drive heart failure and fibrosisJohanna K Freundt, Paulina Hartmann, Christine M Loescher, et al.
Scientific Reports|June 25, 2026
Aortic asprosin overexpression does not ameliorate disease pathophysiology in a murine model of Marfan syndromePrithviraj Manohar Vijaya Shetty, Andrea Matzen, Susanne Hille, et al.
Nature Communications|October 29, 2020
Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variantsJonas Weinmann, Sabrina Weis, Josefine Sippel, et al.
Molecular Therapy. Methods & Clinical Development|January 5, 2024
Regnase-1 overexpression as a therapeutic approach of Marfan syndromeMarie Noormalal, Nesrin Schmiedel, Tarik Bozoglu, et al.
Frontiers in Endocrinology|March 12, 2024
Incidence of microvascular dysfunction is increased in hyperlipidemic mice, reducing cerebral blood flow and impairing remote memoryLuis Daniel Hernandez Torres, Flavia Rezende, Eva Peschke, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 19, 2025
The anti-atherosclerotic effect of chronic AT1 receptor blocker treatment also depends on the ACE2/Ang(1-7)/Mas axisTobias Klersy, Leonie Achner, Benedikt Fels, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 20, 2023
SPSB1-mediated inhibition of TGF-β receptor-II impairs myogenesis in inflammationYi Li, Niklas Dörmann, Björn Brinschwitz, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 8, 2026
Amlodipine improves aortic dysfunction in atherosclerotic miceSophia Marie Rasch, Benedikt Fels, Alexandra Schmalohr, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
Cells|February 11, 2023
C1q and Tumor Necrosis Factor Related Protein 9 Protects from Diabetic Cardiomyopathy by Alleviating Cardiac Insulin Resistance and InflammationRicarda Haustein, Felix A Trogisch, Merve Keles, et al.
JACC. Basic to Translational Science|May 17, 2021
FYCO1 Regulates Cardiomyocyte Autophagy and Prevents Heart Failure Due to Pressure Overload In VivoChristian Kuhn, Maja Menke, Frauke Senger, et al.
Nature Cardiovascular Research|June 16, 2026
Selective titin cleavage disrupts cardiac mechanical homeostasis to drive heart failure and fibrosisJohanna K Freundt, Paulina Hartmann, Christine M Loescher, et al.
Scientific Reports|June 25, 2026
Aortic asprosin overexpression does not ameliorate disease pathophysiology in a murine model of Marfan syndromePrithviraj Manohar Vijaya Shetty, Andrea Matzen, Susanne Hille, et al.
Nature Communications|October 29, 2020
Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variantsJonas Weinmann, Sabrina Weis, Josefine Sippel, et al.
Molecular Therapy. Methods & Clinical Development|January 5, 2024
Regnase-1 overexpression as a therapeutic approach of Marfan syndromeMarie Noormalal, Nesrin Schmiedel, Tarik Bozoglu, et al.
Frontiers in Endocrinology|March 12, 2024
Incidence of microvascular dysfunction is increased in hyperlipidemic mice, reducing cerebral blood flow and impairing remote memoryLuis Daniel Hernandez Torres, Flavia Rezende, Eva Peschke, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|March 19, 2025
The anti-atherosclerotic effect of chronic AT1 receptor blocker treatment also depends on the ACE2/Ang(1-7)/Mas axisTobias Klersy, Leonie Achner, Benedikt Fels, et al.
Journal of Cachexia, Sarcopenia and Muscle|May 20, 2023
SPSB1-mediated inhibition of TGF-β receptor-II impairs myogenesis in inflammationYi Li, Niklas Dörmann, Björn Brinschwitz, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|February 8, 2026
Amlodipine improves aortic dysfunction in atherosclerotic miceSophia Marie Rasch, Benedikt Fels, Alexandra Schmalohr, et al.
Pageof 4